Former Cystic Fibrosis Foundation Employee Sentenced To 10 Months
5/17/2017 A Rockville, Md., man was sentenced to 10 months in prison and three years of supervised release for his role in a scheme involving stolen IT equipment and fraudulent invoicing during his tenure at the Cystic Fibrosis Foundation (CFF). Lowell Meredith ...
CARSTAR and TJ Brodie's Skate in Strides donate $75000 to Cystic Fibrosis Canada
5/17/2017 Calgary, Alberta -- May 17, 2017 -- CARSTAR Canada and the Calgary Flames Foundation in partnership with T.J. Brodie of the Calgary Flames, have presented a $75,000 donation to Cystic Fibrosis Canada. The funds were raised through the Skate In ...
Supporting Piper: Four Hamilton firefighters train for stair climb fundraiser for cystic fibrosis
5/17/2017 Piper Heinz poses with her 4-year-old brother, Wyatt, in front of the four Hamilton Fire Department firefighters who have dedicated this year's Portland Stairclimb to her.
Cystic fibrosis month
5/17/2017 Katie Schulz, Cystic Fibrosis Canada's Hamilton Chapter President, and her daughter Sophia were here this morning to tell us about a big fundraiser taking place on May 29th.
Vertex Looking Forward To Cystic Fibrosis Phase 2 Readouts This Year
5/17/2017 In Quarter One 2017, Vertex adjusted sales increased by 5% over expectations, and earnings per share beat expectations by ~30%. Main growth drivers are proceeding as planned with little competition.
10 Benefits of Having a Service or Therapy Dog When You Have a ...
5/17/2017 Service dogs are typically thought of as necessary companions for the visually impaired, but they can offer assistance to those with lung diseases as well.
Dalton, Arch Plan Joint Production of AB569 for Clinical Trials Involving Treatment-resistant Lung Infections
5/17/2017 Dalton and Arch Biopartners are partnering to manufacture AB569 for clinical trials involving cystic fibrosis (CF) patients with chronic, antibiotic-resistant bacterial lung infections.
Breathing easier: Young Maritimer benefits from increased cystic fibrosis research
5/17/2017 Cystic fibrosis is the most common fatal genetic disease affecting Canadian children and young adults. While there is no cure, advances have been made to increase the life expectancy for those living with it.
New treatments available for cystic fibrosis
5/17/2017 The pediatric pulmonary and sleep medicine program at Helen DeVos Children's Hospital is home to the Cystic Fibrosis Care Center, a multidisciplinary consultative clinic that is accredited by, and a member of, the national Cystic Fibrosis Foundation.
FDA expands approval for Vertex Pharmaceuticals' cystic fibrosis drug
5/17/2017 WASHINGTON - The Food and Drug Administration on Wednesday expanded the approved use of Vertex Pharmaceuticals' Kalydeco (ivacaftor) for treating cystic fibrosis. According to the FDA, the approval triples the number of rare gene mutations that the ...